Ediquit Tablet is a combination medication that belongs to a class of drugs called 'analgesics' used to relieve musculoskeletal pain in the conditions of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. It may also provide relief from acute (short-term) pain such as toothache, ear pain, throat pain, muscle ache, and backache. Pain is caused by damage to the tissues of the muscle and bone for a short time (acute) or long time (chronic).  

Ediquit Tablet contains Bromelain, Rutoside trihydrate, Trypsin, and chymotrypsin. Bromelain, Trypsin, and chymotrypsin are enzymes that have antiseptic and anti-inflammatory properties. They reduce pain, swelling, and inflammation by increasing the blood supply to the affected area. Rutoside trihydrate is an antioxidant and anti-inflammatory agent. It prevents further swelling and inflammation by neutralizing the chemicals (free radicals) that cause cell damage. 

Take Ediquit Tablet as prescribed. Your doctor will advise you on the duration based on your medical condition. In some cases, you may experience vomiting, nausea, diarrhoea, rash, or mouth sores. Most of these side effects of Ediquit Tablet do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.

If you are allergic to Ediquit Tablet or any other medicines, please tell your doctor. Ediquit Tablet should be avoided in patients who are allergic to pineapple, carrot, papaya, fennel, and pollens. Ediquit Tablet is not recommended for pregnant women as it contains Bromelain, which may cause abortion or miscarriage. If you are pregnant or planning for pregnancy, please consult a doctor before taking Ediquit Tablet . Before undergoing any planned surgery, inform your doctor that you are taking Ediquit Tablet . 

Ediquit Tablet contains Bromelain, Rutoside trihydrate, Trypsin, and chymotrypsin used to relieve musculoskeletal pain in the conditions of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. Bromelain, Trypsin, and chymotrypsin are enzymes that have antiseptic and anti-inflammatory properties. They reduce pain, swelling, and inflammation by increasing the blood supply to the affected area. Rutoside trihydrate is an antioxidant and anti-inflammatory agent. It prevents further swelling and inflammation by neutralizing the chemicals (free radicals) that cause cell damage. Thereby, Ediquit Tablet helps relieve pain and inflammation associated with osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis.  

If you are allergic to Ediquit Tablet or any other medicines, please tell your doctor. People allergic to pineapple, carrot, papain, fennel, and pollen should avoid the intake of Ediquit Tablet . Ediquit Tablet is not recommended for pregnant women as it contains Bromelain, which may cause miscarriage, so if you are pregnant or planning for pregnancy, let your doctor know about this. If you are about to undergo any surgery, inform your doctor that you are taking Ediquit Tablet . You are recommended to stop taking Ediquit Tablet a minimum of 2 weeks before surgery as it may increase the risk of bleeding during and after surgery. If you have blood pressure problems, clotting or bleeding problems, infection, hematuria (blood in urine), hematemesis (vomiting blood), kidney or liver disorders, inform your doctor before taking Ediquit Tablet .

Ediquit Tablet must not be used by patients with severe inborn bleeding disorders like haemophilia, severe liver damage, and dialysed patients.